Odoribacter splanchnicus-Derived Extracellular Vesicles Alleviate Inflammatory Bowel Disease by Modulating Gastrointestinal Inflammation and Intestinal Barrier Function via the NLRP3 Inflammasome Suppression

Researchers indicated that Odoribacter splanchnicus-extracellular vesicles (EVs) effectively ameliorated inflammatory bowel disease (IBD) through repressing NLRP3, strongly supporting the potential of probiotic-derived EVs for alleviating IBD.